Carla Lusby, MBA Vice President, Finance
Carla Lusby brings over 18 years of medical device and CDMO experience to Recro, currently serving as vice president of finance. Carla is a key advisor to senior management on company performance and long-term CDMO growth initiatives. She is responsible for Recro’s long and short-term financial planning and the SEC reporting requirements. Carla joined Recro in July 2017 as the denior director of finance and was responsible for consolidating the Acute Care and CDMO segments’ financials.
Carla served as senior director of finance and controller at Baudax Bio, following its spin-out from Recro in November 2019, and is happy to have returned to Recro from Baudax Bio in late 2020. From 2012 to 2017, she worked at DSM Biomedical, a medical device company, serving at multiple sites across the country, and held various roles, including business unit controller, assistant controller, and project manager. Preceding an acquisition from DSM Biomedical, Carla spent nearly ten years at Kensey Nash Corporation, serving in advancing roles in the finance department from Accounting Supervisor to Senior Financial Planning and Analysis Manager.
Carla holds a Bachelor of Science in Business Administration from Cairn University and a Master of Business Administration from Saint Joseph’s University in 2007.